LEADER 03406nam  22006495  450 
001 9910438022103321
005 20200706202239.0
010   $a1-908517-88-3
024 7 $a10.1007/978-1-908517-88-3
035   $a(CKB)3710000000031203
035   $a(EBL)1592995
035   $a(SSID)ssj0001067508
035   $a(PQKBManifestationID)11666519
035   $a(PQKBTitleCode)TC0001067508
035   $a(PQKBWorkID)11092435
035   $a(PQKB)10592823
035   $a(DE-He213)978-1-908517-88-3
035   $a(MiAaPQ)EBC1592995
035   $a(PPN)176102655
035   $a(EXLCZ)993710000000031203
100   $a20131129d2013      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aHandbook of Treatment-resistant Schizophrenia /$fby Leslie Citrome
205   $a1st ed. 2013.
210  1$aTarporley :$cSpringer Healthcare Ltd. :$cImprint: Springer Healthcare,$d2013.
215   $a1 online resource (74 p.)
300   $aDescription based upon print version of record.
311   $a1-908517-86-7 
320   $aIncludes bibliographic references.
327   $aIntroduction -- A general treatment approach -- Adherence ? the great masquerade of treatment-resistance -- Dosing of antipsychotics ? what evidence do we use? -- Psychopharmacological approaches -- Somatic treatments -- Nonpharmacological approaches -- Conclusions.
330   $aHandbook of Treatment-resistant Schizophrenia is a concise review of treatment-resistant schizophrenia?s definition, measurement tools, adherence issues, substance abuse, optimal dosing, clinician?patient relationships, and current management approaches. The book was originally commissioned with the intention of creating a comprehensive text focusing on treatment-resistant schizophrenia and its management. The book explores many aspects of the background and practice- and research-based evidence for treating this complex subset of schizophrenia, including psychopharmacological, somatic, and nonpharmacological treatment approaches. While exploring the various therapies for treatment-resistant schizophrenia, Dr Citrome also emphasizes the importance of building strong and trusting relationships between patients and their clinicians so the clinician can best manage their patient?s adherence and overall treatment.
606   $aMedicine
606   $aPsychology
606   $aPsychiatry
606   $aPharmacy
606   $aMedicine/Public Health, general$3https://scigraph.springernature.com/ontologies/product-market-codes/H00007
606   $aPsychology, general$3https://scigraph.springernature.com/ontologies/product-market-codes/Y00007
606   $aPsychiatry$3https://scigraph.springernature.com/ontologies/product-market-codes/H53003
606   $aPharmacy$3https://scigraph.springernature.com/ontologies/product-market-codes/F00008
615  0$aMedicine.
615  0$aPsychology.
615  0$aPsychiatry.
615  0$aPharmacy.
615 14$aMedicine/Public Health, general.
615 24$aPsychology, general.
615 24$aPsychiatry.
615 24$aPharmacy.
676   $a616.89806
700   $aCitrome$b Leslie$4aut$4http://id.loc.gov/vocabulary/relators/aut$0926180
906   $aBOOK
912   $a9910438022103321
996   $aHandbook of Treatment-resistant Schizophrenia$92079602
997   $aUNINA